Today South Australia Police (SAPOL) launched the landmark 'Go for PSO' campaign, showcasing the diverse and meaningful career opportunities available ...
ORKA-002 interim Phase 1 data demonstrates a half-life of 75-80 days supporting potential for twice-per-year dosing in ...
In an open-label phase 3b trial, the co-administration of Lilly’s IL-17A antagonist Taltz (ixekizumab) and dual GIP/GLP-1 ...
On Thursday, Eli Lilly and Co. (NYSE:LLY) revealed topline results from the novel TOGETHER-PsA open-label Phase 3b trial ...
Air Charter Scotland has announced the relaunch of its Aberdeen-Wick route, with flights set to commence on 14 January.
Experts and private sector executives acknowledged the government’s efforts to develop the energy sector but pointed out ...
South Australia's first-ever campaign to drive police security officer (PSO) applications will launch this week as part of the State Government's ...
Oklahoma balances oil and gas roots with growing wind and solar, debating taxes, reliability and regulation as energy demand ...
The KSE-100 Index surged by 6,634 points, registering a week-on-week increase of 3.8%, to settle at 179,035 points, compared ...
Specialist police armed with semi-automatic rifles will patrol Melbourne Park during the Australian Open as an “additional ...
The American Red Cross urges donors to make an appointment to give blood or platelets now to keep the blood supply as strong ...
Topline data were announced from a phase 3b trial evaluating the concomitant use of ixekizumab and tirzepatide in adults with active psoriatic arthritis and obesity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results